[
    [
        {
            "time": "",
            "original_text": "【医药-马帅】医药行业19H1总结：二季度业绩环比提速，关注政策免疫与基本面改善板块",
            "features": {
                "keywords": [
                    "医药行业",
                    "19H1总结",
                    "二季度业绩",
                    "环比提速",
                    "政策免疫",
                    "基本面改善"
                ],
                "sentiment_score": 0.75,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药-马帅】医药行业19H1总结：二季度业绩环比提速，关注政策免疫与基本面改善板块",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]